Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel Pd-catalyzed route for penta-hepta-homopiperazinone derivatives offers high yield and mild conditions for scalable API intermediate production.
Novel NBS-mediated synthesis of alpha-1,3,5-triazinethioketones offers high purity and cost-effective manufacturing for anti-tumor drug development pipelines.
Patent CN114853838B reveals a low-cost, high-yield preparation method for abiraterone acetate, offering significant supply chain advantages for pharmaceutical manufacturers.
Patent CN104356043A reveals high-yield oxidation method. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable supply chain reliability.
Novel chiral preparation of Cinacalcet HCl via Patent CN101993379B. Eliminates toxic reductants, ensures high optical purity, and offers scalable API intermediate manufacturing solutions.
Patent CN119546579A enables high-yield synthesis of prostate cancer drug intermediates, ensuring supply chain stability and significant cost efficiency.
Patent CN105712918B reveals a high-yield lactam synthesis using synergistic catalysis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Advanced catalytic route for Pentafluorobenzonitrile ensures high purity and supply stability for global quinolone manufacturing chains efficiently.
Discover advanced manufacturing of chiral 1,4-dihydro-4-(3-nitrophenyl)-3,5-pyridinedicarboxylates. A robust resolution process for calcium antagonist intermediates ensuring high purity and supply stability.
Discover the novel CN102770420A process for Dronedarone synthesis. Achieve high yields and purity with streamlined manufacturing for reliable pharmaceutical supply chains.
Novel asymmetric synthesis method for sitafloxacin intermediate ensures high optical purity and scalable production for global pharmaceutical supply chains seeking reliable partners.
Patent CN102249937A details a low-cost, non-toxic synthesis for Ivabradine intermediates, offering significant supply chain advantages for API manufacturers.
Novel preparation method for Mitapivat ensures high purity and yield. Optimized process reduces costs and enhances supply chain reliability for global pharmaceutical manufacturers.
Patent CN1269795A reveals a scalable route for chiral alkoxyfuranone derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN108997247A discloses efficient oxidation route for Rivaroxaban intermediate enabling cost reduction in API manufacturing and supply chain reliability.
Patent CN118619916A reveals additive-free synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN102939285A reveals green cyclization for Aprepitant. Reduces toxicity and energy. Ensures high purity supply chain continuity for global buyers.
Patent CN111440151A details a streamlined 3-step synthesis of Pralsetinib using Rieke Zinc coupling, offering high purity >99.6% and reduced manufacturing costs.
Patent CN101163698B reveals efficient Pd-catalyzed coupling and reductive amination routes for 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide, offering significant supply chain advantages.
Patent CN106187657A reveals stable PdMgAl-LDH catalyst for Suzuki reactions. Reduces palladium pollution and enables scalable pharmaceutical intermediates manufacturing with cost efficiency.